Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis
Cong Liu, Junghwan Lee, Casey Ta, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 5, pp. e35311-e35311
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review
Jola Bytyci, Yuxin Ying, Lennard Y. W. Lee
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 9
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants
Stacia M. DeSantis, Ashraf Yaseen, Tianyao Hao, et al.
The Journal of Infectious Diseases (2023) Vol. 227, Iss. 10, pp. 1164-1172
Open Access | Times Cited: 10
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)
Giulia Vivaldi, David A. Jolliffe, Hayley Holt, et al.
The Lancet Regional Health - Europe (2022) Vol. 22, pp. 100501-100501
Open Access | Times Cited: 16
Epidemiology, clinical features and outcomes of hospitalized patients with COVID-19 by vaccination status: a multicenter historical cohort study
Shatha Alshanqeeti, Susan Szpunar, Premchand Anne, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021
Alberto Mateo‐Urdiales, Massimo Fabiani, Flávia Mayer, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis
Xueying Yang, Jiajia Zhang, Shujie Chen, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2024) Vol. 97, Iss. 2, pp. 107-116
Closed Access | Times Cited: 2
Clinical features and severe outcome predictors of COVID-19 vaccine breakthrough infection among hospitalized patients: results from Egypt severe acute respiratory infections sentinel surveillance, 2021–2022
Amr Kandeel, Manal Fahim, Ola Deghedy, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Detection of hospital environmental contamination during SARS-CoV-2 Omicron predominance using a highly sensitive air sampling device
Kai Sen Tan, Alicia Xin Yu Ang, Douglas Jie Wen Tay, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 5
Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment
Adel A. Gomaa, Yasmin A. Abdel-Wadood, Mohamed Gomaa
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 1977-1992
Open Access | Times Cited: 8
The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data
Meghana Kshirsagar, Md Nasir, Sumit Mukherjee, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 11, pp. e38898-e38898
Open Access | Times Cited: 8
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
Sharon Walmsley, Majid Nabipoor, Leif E. Lovblom, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 36-36
Open Access | Times Cited: 4
Changes in Infectious Disease–Specific Health Literacy in the Post–COVID-19 Pandemic Period: Two-Round Cross-Sectional Survey Study
Yusui Zhao, Yue Xu, Dingming Yao, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e52666-e52666
Open Access | Times Cited: 1
Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago
Fabiola M Moreno Echevarria, Mathew Caputo, Daniel M. Camp, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0302338-e0302338
Open Access | Times Cited: 1
Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients
Yeşim Yıldız, Emre Yaşar, Erensu Öztürk, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 11
Open Access | Times Cited: 1
Resident Factors Associated With Breakthrough SARS-CoV-2 Infections
Ana Montoya, Katherine Wen, Jasmine Travers, et al.
Journal of the American Medical Directors Association (2023) Vol. 24, Iss. 6, pp. 901-905
Open Access | Times Cited: 3
SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022
Richard A. Teran, Alexandra Gagner, Stephanie Gretsch, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 11
Open Access | Times Cited: 2
The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19
Yeşim Yıldız, Hasan Selçuk Özger, Ali Acar, et al.
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 2, pp. 118-126
Open Access | Times Cited: 1
Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individuals.
Fabiola M Moreno Echevarria, Mathew T. Caputo, Daniel M. Camp, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
Constant Gillot, Marie Tré‐Hardy, Roberto Cupaiolo, et al.
Virology (2024) Vol. 595, pp. 110082-110082
Open Access
Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV- POPART cohort participants
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, et al.
Research Square (Research Square) (2024)
Closed Access
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
Leonardo Palazzo, Julius Lindblom, Emelie Kihlgren Olsson, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1923-1933
Open Access
SARS-COV-2 BREAKTHROUGH INFECTION AND ITS COVARIATES AMONG HEALTHCARE PROVIDERS OF A HOSPITAL IN BANGLADESH DURING THE OMICRON WAVE
Masfida Akhter, Suman Kumar Roy, Abul Khair, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37287-e37287
Open Access
Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
CoronaVac, BNT162b2 and heterologous COVID-19 vaccine outcomes in patients with ventricular assist device
Mehmet Karahan, Ümit Kervan, Sınan Sabit Kocabeyoğlu, et al.
The International Journal of Artificial Organs (2022) Vol. 46, Iss. 1, pp. 15-21
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top